Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Susceptibility for Lupus Nephritis by Low Copy Number of the FCGR3B Gene Is Linked to Increased Levels of Pathogenic Autoantibodies.

Nossent JC, Becker-Merok A, Rischmueller M, Lester S.

Autoimmune Dis. 2013;2013:750814. doi: 10.1155/2013/750814. Epub 2013 Jun 20.

2.

Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature.

Gunnarsson R, Andreassen AK, Molberg Ø, Lexberg ÅS, Time K, Dhainaut AS, Bertelsen LT, Palm Ø, Irgens K, Becker-Merok A, Nordeide JL, Johnsen V, Pedersen S, Prøven A, Garabet LS, Garen T, Aaløkken TM, Gilboe IM, Gran JT.

Rheumatology (Oxford). 2013 Jul;52(7):1208-13. doi: 10.1093/rheumatology/kes430. Epub 2013 Feb 12. Review.

PMID:
23407386
3.

Circulating interferon-α2 levels are increased in the majority of patients with systemic lupus erythematosus and are associated with disease activity and multiple cytokine activation.

Becker-Merok A, Østli-Eilersten G, Lester S, Nossent J.

Lupus. 2013 Feb;22(2):155-63. doi: 10.1177/0961203312468964. Epub 2012 Dec 4.

PMID:
23213068
4.

Prevalence and severity of interstitial lung disease in mixed connective tissue disease: a nationwide, cross-sectional study.

Gunnarsson R, Aaløkken TM, Molberg Ø, Lund MB, Mynarek GK, Lexberg AS, Time K, Dhainaut AS, Bertelsen LT, Palm O, Irgens K, Becker-Merok A, Nordeide JL, Johnsen V, Pedersen S, Prøven A, Garabet LS, Gran JT.

Ann Rheum Dis. 2012 Dec;71(12):1966-72. doi: 10.1136/annrheumdis-2011-201253. Epub 2012 May 1.

PMID:
22550317
5.

Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus.

Eilertsen GØ, Nikolaisen C, Becker-Merok A, Nossent JC.

Lupus. 2011 May;20(6):607-13. doi: 10.1177/0961203310392432. Epub 2011 Mar 21.

PMID:
21422077
6.

Work disability in patients with ankylosing spondylitis in Norway.

Bakland G, Gran JT, Becker-Merok A, Nordvåg BY, Nossent JC.

J Rheumatol. 2011 Mar;38(3):479-84. doi: 10.3899/jrheum.100686. Epub 2011 Feb 1.

PMID:
21285159
7.

Levels of transforming growth factor-beta are low in systemic lupus erythematosus patients with active disease.

Becker-Merok A, Eilertsen GØ, Nossent JC.

J Rheumatol. 2010 Oct;37(10):2039-45. doi: 10.3899/jrheum.100180. Epub 2010 Aug 3.

PMID:
20682675
8.

Prevalence, predictors and outcome of vascular damage in systemic lupus erythematosus.

Becker-Merok A, Nossent J.

Lupus. 2009 May;18(6):508-15. doi: 10.1177/0961203308099233.

PMID:
19395452
9.

The influence of the 1997 updated classification criteria for systemic lupus erythematosus: epidemiology, disease presentation, and patient management.

Eilertsen GØ, Becker-Merok A, Nossent JC.

J Rheumatol. 2009 Mar;36(3):552-9. doi: 10.3899/jrheum.080574. Epub 2009 Jan 22.

PMID:
19208593
11.

Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.

Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.

Arthritis Res Ther. 2006;8(6):R162.

12.
13.

Antiphospholipid antibody syndrome in autoimmune hepatitis.

Becker-Merok A, Nossent H.

Isr Med Assoc J. 2005 Apr;7(4):268-9. No abstract available.

14.

Fibrosing alveolitis predating microscopic polyangiitis.

Becker-Merok A, Nossent JC, Ritland N.

Scand J Rheumatol. 1999;28(4):254-6.

PMID:
10503564

Supplemental Content

Loading ...
Support Center